Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MERGERS AND ACQUISITIONS
Stock Market Drop Not Seen Dampening Healthcare Deal Activity
By Armie Margaret Lee
Feb 8, 2018 6:48 PM EST
STOCKS
Biotech, pharma stocks tumble amid big market sell-off
By Armie Margaret Lee
Feb 5, 2018 4:30 PM EST
STOCKS
Sanofi announces second billion-dollar deal in a week, and it may not be done
By Armie Margaret Lee
Jan 29, 2018 1:59 PM EST
FUTURES
5G, Sanofi, Ablynx, Coincheck and Bruno Mars - 5 Things You Must Know Before the Market Opens
By Joseph Woelfel
Jan 29, 2018 7:42 AM EST
MERGERS AND ACQUISITIONS
Why 2018 will be better for biotech deals than 2017
By Armie Margaret Lee
Jan 25, 2018 7:15 PM EST
MARKETS
Dow, S&P 500 and Nasdaq Hit New Records as Senate Reaches Deal to End Shutdown
By Joseph Woelfel
Jan 22, 2018 4:12 PM EST
MARKETS
Dow, S&P 500 and Nasdaq Shake Off Government Shutdown to Trade Higher
By Joseph Woelfel
Jan 22, 2018 10:17 AM EST
VIDEO
A Government Shutdown Won't Crush Stock Market, a New England Patriots Win Will
By Brian Sozzi
Jan 22, 2018 8:48 AM EST
STOCKS
Will the Government Shutdown Kill the Mind-Blowing Bull Market?
By Brian Sozzi
Jan 22, 2018 8:04 AM EST
VIDEO
Government Shutdown and Everything Else You Need to Know Monday Morning
By Daniel Kuhn
Jan 22, 2018 7:21 AM EST
FUTURES
Shutdown Enters Day 3, Sanofi Buys Bioverativ - 5 Things You Must Know Before the Market Opens
By Joseph Woelfel
Jan 22, 2018 6:53 AM EST
MERGERS AND ACQUISITIONS
Sanofi Strikes $11.6 Billion Deal for Bioverativ
By Paul Whitfield
Jan 22, 2018 6:07 AM EST
STOCKS
Morgan Stanley Just Found 37 Challenged Stocks That Still Have No Hope
By Kinsey Grant
Oct 26, 2017 12:52 PM EDT
STOCKS
Biogen Shares Down Amid Lower-Than-Expected Q3 Spinraza U.S. Sales
By Armie Margaret Lee
Oct 24, 2017 4:10 PM EDT
HEALTH
Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite
By Armie Margaret Lee
Jul 25, 2017 12:35 PM EDT
OPINION
IBM Is One of 18 Companies That Could Soon Be Attacked by an Activist Investor
By Brian Sozzi
Jul 25, 2017 10:04 AM EDT
STOCKS
How President Trump Has Sent Biotech Stocks Soaring
By William McConnell
Jun 23, 2017 8:52 PM EDT
STOCKS
One Insider Just Bought $65 Million Worth of This Expensive Biotech Stock
By Roberto Pedone
Jun 7, 2017 8:45 PM EDT
STOCKS
Insiders Love Bioverativ, Juno Therapeutics and More
By Roberto Pedone
May 31, 2017 1:11 PM EDT
STOCKS
Biotech's are quite active Tuesday. Find Out who's moving and why:
By William McConnell
Apr 25, 2017 9:59 AM EDT
JIM CRAMER
Valuation Is in the Eye of the Buyer: Cramer's 'Mad Money' Recap
By Bret Kenwell
Apr 4, 2017 9:02 PM EDT
STOCKS
Analysts' Actions -- Boeing, Blueprint Medicines, Rockwell Collins, Johnson Controls and More
By Deal Desk
Mar 13, 2017 9:43 AM EDT
INVESTING
Ring the register with these upcoming spinoffs
By David Sterman
Feb 24, 2017 7:35 AM EST
